This inventor holds 3 USPTO granted patents and 7 published patent applications and 2 EPO patents. Top assignees: Jiangsu Puxin Pharmaceutical Co., Ltd., Shanghai Cerong Network Technology Co., Ltd., Shanghai Desano Pharmaceutical Co., Ltd.. Active years: 2019-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 3 
1 out of 1 Years Active: 2019-2025
Title: Fei Jiang: Innovator in Pharmaceutical Development
Introduction
Fei Jiang is a prominent inventor based in Shanghai, China, known for his contributions to the pharmaceutical industry. With a total of three patents to his name, he has made significant strides in developing innovative medical solutions.
Latest Patents
Among his latest patents is a lift chair, which showcases his commitment to enhancing patient mobility and comfort. Additionally, he has developed bicyclic substituted sulfonylurea compounds as inhibitors of interleukin-1 activity. This application relates to novel bicyclic substituted sulfonylurea compounds and analogues, their manufacture, pharmaceutical compositions comprising them, and their use as medicaments for treating diseases associated with modulation of cytokines such as IL-1β and IL-18, modulation of NLRP3, or inhibition of the activation of NLRP3 or related components of the inflammatory process.
Career Highlights
Fei Jiang has worked with notable companies in the pharmaceutical sector, including Viva Star Biosciences (Suzhou) Co., Ltd. and Shanghai Desano Pharmaceutical Co., Ltd. His work in these organizations has contributed to advancements in drug development and therapeutic solutions.
Collaborations
Throughout his career, Fei Jiang has collaborated with esteemed colleagues such as Ping Chen and Hongjian Zhang. These partnerships have fostered innovation and have been instrumental in his research endeavors.
Conclusion
Fei Jiang's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a key innovator. His work continues to impact the medical community positively, paving the way for future advancements in treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile